According to the World Health Organization, approximately 280 million people worldwide experience depression at any point in time. In the United States, 21 million people suffer from major depressive ...

The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...

Dimethyltryptamine’s short duration of psychedelic effects makes it a potentially practical alternative to other longer-acting psychedelic therapies such as psilocybin.

Major depressive disorder (MDD), perhaps the most common form of depression (APA, 2013), has many subtypes, each with its unique characteristics and treatment needs. I was recently reviewing this with ...

Objective To estimate the efficacy of exercise on depressive symptoms compared with non-active control groups and to determine the moderating effects of exercise on depression and the presence of ...